Close

Galena Biopharma (GALE) Receives Notice of Allowance of U.S. Patent for NeuVax

February 8, 2016 7:37 AM EST Send to a Friend
Galena Biopharma, Inc. (NASDAQ: GALE) today announced the United States Patent Office issued a Notice of Allowance for an additional ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login